• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高凝状态表明沃纳综合征中动脉粥样硬化的一个额外风险因素。

Hypercoagulable state indicates an additional risk factor for atherosclerosis in Werner's syndrome.

作者信息

Goto M, Kato Y

机构信息

Division of Rheumatic Diseases, Tokyo Metropolitan Otsuka Hospital, Japan.

出版信息

Thromb Haemost. 1995 Apr;73(4):576-8.

PMID:7495061
Abstract

To assess the risk factors for atherosclerosis in Werner's syndrome (WS), coagulation/fibrinolytic system parameters and lipid levels were investigated in 9 non-smoker patients with WS and compared with normal control values (N). The levels of thrombin antithrombin III complex (p < 0.05), D-dimer (p < 0.05), tissue plasminogen activator (p < 0.005) and PA inhibitor 1 (p < 0.01) were significantly increased, while the level of thrombomodulin (p < 0.005) in the fasting plasma was significantly decreased in the WS cases compared with N. Lipid profiles confirmed that 8 of the 9 patients were of hyperlipidemia type IIb, 7 had hyperinsulinemia and 5 fulfilled the criteria for clinical diabetes mellitus. The hypercoagulable condition suggested the existence of multiple risk factors for atherosclerosis in WS in addition to the previously reported hyperinsulinemia and hyperlipidemia.

摘要

为评估沃纳综合征(WS)患者动脉粥样硬化的危险因素,对9例不吸烟的WS患者的凝血/纤溶系统参数和血脂水平进行了研究,并与正常对照值(N)进行比较。与N相比,WS患者空腹血浆中凝血酶 - 抗凝血酶III复合物水平(p < 0.05)、D - 二聚体水平(p < 0.05)、组织纤溶酶原激活物水平(p < 0.005)和PA抑制剂1水平(p < 0.01)显著升高,而血栓调节蛋白水平(p < 0.005)显著降低。血脂谱证实,9例患者中有8例为IIb型高脂血症,7例有高胰岛素血症,5例符合临床糖尿病标准。这种高凝状态表明,除了先前报道的高胰岛素血症和高脂血症外,WS患者还存在多种动脉粥样硬化危险因素。

相似文献

1
Hypercoagulable state indicates an additional risk factor for atherosclerosis in Werner's syndrome.高凝状态表明沃纳综合征中动脉粥样硬化的一个额外风险因素。
Thromb Haemost. 1995 Apr;73(4):576-8.
2
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.
3
Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.原发性甲状旁腺功能亢进患者的血液凝固、纤维蛋白溶解和血脂谱:血浆因子VII和X活性及D-二聚体水平升高。
Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):619-24. doi: 10.1055/s-2008-1065365. Epub 2008 May 16.
4
Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.肝切除术后与伤口愈合相关的术后高凝状态继之以高纤维蛋白溶解状态。
J Am Coll Surg. 1996 Sep;183(3):230-8.
5
Fibrinolytic activity in peripheral atherosclerosis in the elderly.老年人外周动脉粥样硬化中的纤溶活性。
Thromb Haemost. 1999 Feb;81(2):275-80.
6
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.口服避孕甾体激素对动脉血栓形成生化标志物的药效学作用。非糖尿病女性和胰岛素依赖型糖尿病女性的研究。
Dan Med Bull. 2002 Feb;49(1):43-60.
7
Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.2型糖尿病患者急性给予那格列奈:对餐后代谢、凝血和纤维蛋白溶解的影响。
Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):6-12. doi: 10.1016/j.numecd.2004.06.002.
8
[Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].[急性肺血栓栓塞症患者治疗后血液凝血和纤溶系统及肺血管内皮功能的变化]
Zhonghua Yi Xue Za Zhi. 2007 Nov 20;87(43):3074-8.
9
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group.纤维蛋白周转增加及纤溶能力缺陷与下肢动脉粥样硬化的关联。PLAT研究组。
Thromb Haemost. 1994 Aug;72(2):292-6.
10
Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.生长激素缺乏的成年人长期接受生长激素治疗可降低纤溶酶原激活物抑制剂-1和组织纤溶酶原激活物水平。
Thromb Haemost. 1996 Sep;76(3):422-8.